调整到miRNAs:对它们对诊断的影响和喘进展的全面分析
Mahmoud A Elrebehy1, Ahmed I Abulsoud2, Walaa A El-Dakroury3
1Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Cairo 11829, Egypt.
Pathology, research and practice
|January 21, 2024
概括
微RNAs (miRNAs) 是喘中的关键表观遗传调节者,影响疾病亚型和进展. 它们作为生物标志物的作用有助于个性化治疗选择和改善患者管理.
科学领域:
- * 呼吸系统医学 呼吸系统医学
- * 分子生物学 * 分子生物学
- * 免疫学 免疫学
背景情况:
- *喘是一种复杂的炎症性呼吸道疾病,有多种不同的亚型.
- *表观遗传调节,特别是microRNAs (miRNAs),影响喘病原性.
- *miRNAs调节免疫细胞功能和呼吸道结构细胞行为.
研究的目的:
- *审查miRNAs在喘中的功能性作用.
- *为了阐明miRNAs在喘中的调节机制.
- *评估miRNAs作为喘分类和治疗选择的生物标志物的实用性.
主要方法:
- *对目前关于喘中miRNAs的研究进行文献综述.
- *分析气道炎症中的miRNA调节通路.
- * 在喘亚型中评估miRNA生物标志物潜力.
主要成果:
- *miRNAs调节关键的细胞过程,包括生存,增殖和呼吸道中介体的产生.
- *特定的miRNA配置文件与不同的喘表型有关.
- *miRNAs显示出作为诊断和预后生物标记物的希望.
结论:
- *miRNAs是喘病理生理学和进展的组成部分.
- *miRNAs可以作为用于喘亚型和个性化医学的有价值的生物标志物.
- *针对miRNAs可能为喘管理提供新的治疗策略.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Asthma: Pathogenesis and Management
405
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
405
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K


